EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

The involvement of the MET oncogene in de novo and acquired resistance of non-small cell lung cancers (NSCLC) to tyrosine kinase inhibitors (TKIs) has been reported, but the precise mechanism by which MET overexpression contributes to TKI-resistant NSCLC remains unclear. MicroRNAs (miRNAs) negativel...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Garofalo, Michela, Romano, Giulia, Di Leva, Gianpiero, Nuovo, Gerard, Jeon, Young-Jun, Ngankeu, Apollinaire, Sun, Jin, Lovat, Francesca, Alder, Hansjuerg, Condorelli, Gerolama, Engelman, Jeffrey A, Ono, Mayumi, Rho, Jin Kyung, Cascione, Luciano, Volinia, Stefano, Nephew, Kenneth P., Croce, Carlo M.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2011
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3467100/
https://ncbi.nlm.nih.gov/pubmed/22157681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.2577
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים